PillTracker Overview
PillTracker is an adherence system that helps patients and doctors collaboratively manage medication consumption. Leveraging a patented conductive layer, advanced Qualcomm chipset, and a familiar Android-based user interface, PillTracker streamlines adherence throughout the lifecycle of the medication for the patient and doctor alike. PillTracker approaches medication adherence from both directions, reminding the patient about their prescribed dose, while tracking their medication use in near-real time on behalf of the healthcare provider. All of this is made possible by smart blister packaging paired with a user-friendly medication dispenser. PillTracker enables precise and efficient clinical trials by tracking medication use in near-real time, accepting patient feedback, and offering direct engagement between study staff and participants. PillTracker extends electronic clinical trial management systems into the hands of the patient. Additionally, study staff can update prescribed dosing for patients, send them notifications, and accept formal case report forms through the device.
Cumulative Funding Raised Over Time ($)
—Dec 2019
$400KFeb 2017
Latest News
growth-positive
PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority
Israeli medication adherence start-up PillTracker has joined the PMatX Innovation Lab to accelerate the development of its medication adherence solution. The lab, operated by M Ventures and supported by Merck, FLEX, and the Israel Innovation Authority, serves as an innovation lab for Israeli start-ups developing next-generation electronics innovations. PillTrackers technology, which uses cellular-enabled smart packaging and cloud-connectivity, initially targets medication adherence in clinical trials and will expand to support patient compliance for post-market specialty pharmaceuticals. The company will receive funding and strategic mentorship support from Merck, Flex, and the Israel Innovation Authority through the PMatX program. PillTracker aims to launch its next-generation clinical trial medication compliance platform in Q2 2020.
Partners
growth-positive
BIRD to invest $7 million in 8 new Israel-US projects
The Israel-US Binational Industrial Research and Development (BIRD) Foundation has approved $7 million in funding for eight new projects between American and Israeli companies. The projects cover various areas such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The funding from BIRD will be supplemented by private sector funding, bringing the total value of the projects to approximately $18.5 million. The BIRD Foundation has been instrumental in promoting collaboration between US and Israeli companies, with a total investment of about $340 million in joint projects. This funding will further support the growth and development of valuable collaborations between companies in both countries.
Investment
growth-positive
https://www.jpost.com/Israel-News/Israel-US-foundation-commits-7m-to-eight-hi-tech-R-and-D-partnerships-498221
The Israel-US Binational Industrial Research and Development Foundation (BIRD) will invest $7 million in eight new Israeli-American projects across various hi-tech disciplines. The projects will receive conditional grants of up to $1 million each, focusing on topics such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The companies involved will also have access to private sector funding, bringing the total value of the projects to $18.5 million. The funding was approved on June 14 at a BIRD board of governors meeting in Washington. BIRD, established in 1977, has invested over $340 million in joint projects, generating more than $10 billion in direct and indirect revenue.
Investment
growth-positive
BIRD - Israel-U.S. Binational Industrial R&D Foundation to Invest $7 Million in Eight New Projects
The BIRD Foundation, a collaboration between U.S. and Israeli companies, has approved $7 million in funding for eight new projects. These projects will also access private sector funding, bringing the total value to approximately $18.5 million. The BIRD Foundation promotes joint product development and provides grants of up to $1 million for approved projects. The projects approved cover a range of technological fields, including 3D culture platforms, colon cancer screening systems, and personalized nutrition recommendations. The BIRD Foundation has approved over 940 projects in its 40-year history, with a total investment of about $340 million. The deadline for the next project cycle is September 7, 2017.
PartnersInvestment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1.22M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 4 |
| Investors | 3 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | pilltracker.com |
Locations
HaPelech St 7, Tel Aviv-Yafo, Israel
New York, NY, USA
Photos & Videos
3 item(s)
PillTracker Business
Business models
B2B, B2B2C
Product stage
Alpha
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcarePatient EngagementTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersCore Technology
Platforms & InterfacesMobileSemiconductors & ElectronicsPrinted Circuit BoardTags (19)
data-analyticsmhealthpharma-companiescloudcompliancemonitoringauthenticationconsumer-electronicsdigital-healthcaremedicationsensorsbiometricspharmaceuticalsbehavior-analyticsadherencemobile-applicationsiottreatmentspatient-engagementGeographic Markets
North AmericaUnited StatesAfricaAustraliaUnited KingdomEuropePillTracker Financials
$1.22M
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Seed
Funding stage
4
Total rounds
3
Investors
Cumulative Funding Raised Over Time ($)
—Dec 2019
$400KFeb 2017
Private Equity Funding
Seed
Dec 2019
Undisclosed
M Ventures, PMatX
Seed
Feb 2017
$400K
Dr. Gil Mileikowsky
Non-Equity Funding
GrantEvent
Jul 2017
$700K
BIRD Foundation
GrantEvent
Jul 2016
$120K
Israel Innovation Authority, Shenzhen Governemnt
PillTracker Lifecycle
Cumulative Funding Raised Over Time
—Dec 2019
$400KFeb 2017
All Events
Seed
Dec 2019
Undisclosed
M Ventures, PMatX
Seed
Feb 2017
$400K
Dr. Gil Mileikowsky
GrantEvent
Jul 2017
$700K
BIRD Foundation
GrantEvent
Jul 2016
$120K
Israel Innovation Authority, Shenzhen Governemnt
PillTracker News
4 articles
growth-positive
PillTracker Ltd. Joins PMatX Innovation Lab, to Accelerate Development With Support From Merck, Flex and Israel Innovation Authority
Israeli medication adherence start-up PillTracker has joined the PMatX Innovation Lab to accelerate the development of its medication adherence solution. The lab, operated by M Ventures and supported by Merck, FLEX, and the Israel Innovation Authority, serves as an innovation lab for Israeli start-ups developing next-generation electronics innovations. PillTrackers technology, which uses cellular-enabled smart packaging and cloud-connectivity, initially targets medication adherence in clinical trials and will expand to support patient compliance for post-market specialty pharmaceuticals. The company will receive funding and strategic mentorship support from Merck, Flex, and the Israel Innovation Authority through the PMatX program. PillTracker aims to launch its next-generation clinical trial medication compliance platform in Q2 2020.
Partners
growth-positive
BIRD to invest $7 million in 8 new Israel-US projects
The Israel-US Binational Industrial Research and Development (BIRD) Foundation has approved $7 million in funding for eight new projects between American and Israeli companies. The projects cover various areas such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The funding from BIRD will be supplemented by private sector funding, bringing the total value of the projects to approximately $18.5 million. The BIRD Foundation has been instrumental in promoting collaboration between US and Israeli companies, with a total investment of about $340 million in joint projects. This funding will further support the growth and development of valuable collaborations between companies in both countries.
Investment
growth-positive
https://www.jpost.com/Israel-News/Israel-US-foundation-commits-7m-to-eight-hi-tech-R-and-D-partnerships-498221
The Israel-US Binational Industrial Research and Development Foundation (BIRD) will invest $7 million in eight new Israeli-American projects across various hi-tech disciplines. The projects will receive conditional grants of up to $1 million each, focusing on topics such as autonomous vehicles, biotechnology, digital health, homeland security, and nanotechnology. The companies involved will also have access to private sector funding, bringing the total value of the projects to $18.5 million. The funding was approved on June 14 at a BIRD board of governors meeting in Washington. BIRD, established in 1977, has invested over $340 million in joint projects, generating more than $10 billion in direct and indirect revenue.
Investment
growth-positive
BIRD - Israel-U.S. Binational Industrial R&D Foundation to Invest $7 Million in Eight New Projects
The BIRD Foundation, a collaboration between U.S. and Israeli companies, has approved $7 million in funding for eight new projects. These projects will also access private sector funding, bringing the total value to approximately $18.5 million. The BIRD Foundation promotes joint product development and provides grants of up to $1 million for approved projects. The projects approved cover a range of technological fields, including 3D culture platforms, colon cancer screening systems, and personalized nutrition recommendations. The BIRD Foundation has approved over 940 projects in its 40-year history, with a total investment of about $340 million. The deadline for the next project cycle is September 7, 2017.
PartnersInvestment
PillTracker Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 3 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 12 classification IDs that could be used for matching.
PillTracker Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515365864 |
| Crunchbase | pilltracker-ltd |
| Creator | Shmuel (Sam) Rausnitz |
| Creator email | shmuel.rausnitz@sncentral.org |
| Last updater | Orli Wollner |
| Updater email | orlushka@gmail.com |
| Last update | 2020-12-14T00:00:00.000Z |
| Created | 2017-01-05T00:00:00.000Z |
| Claimed | Yes |